Market Research Logo

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France

Summary

GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in France. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of France. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

In 2010, the French pharmaceutical market was worth $36.5B, which decreased to an estimated $33.5B in 2017 at a negative Compound Annual Growth Rate (CAGR) of 1.5%. The French medical devices market was valued at $17.7B in 2015, which increased to $19B in 2017. The market is expected to grow at a CAGR of 4% from $19.7B in 2018 to $21.2B in 2020. Regulatory reforms have led to faster and more efficient drug approval processes. The French healthcare system provides universal health coverage, healthcare reimbursement, and open healthcare access with implementation of E-health card for the French people.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the France, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Pfizer, Sanofi, Servier, Pierre Fabre and Ipsen) and profiles and SWOT analyses of the major players in the medical device market (Roche, Medtronic, Abbott, Siemens and Boston Scientific)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of France
  • Porter’s five forces analysis for pharmaceutical and medical devices market of France
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the French healthcare market.
Reasons to buy

The report provides information on the healthcare, regulatory, and reimbursement landscape in the France, and includes -
  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Pfizer, Sanofi, Servier, Pierre Fabre and Ipsen) and profiles and SWOT analyses of the major players in the medical device market (Roche, Medtronic, Abbott, Siemens and Boston Scientific)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of France
  • Porter’s five forces analysis for pharmaceutical and medical devices market of France
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the French healthcare market.


Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porter’s Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix
List of Tables
Table 1: Pharmaceutical Market, France, Sales of Patented Drug Products by Major Therapeutic Class at Ex factory Prices (%), 2017
Table 2: Medical Device Market, France, Revenue by Segment ($B), 2017
Table 3: IVD Market, France, Revenue ($M) and Market Share (%) of Major Companies
Table 4: Cardiovascular Devices , France, Revenue ($M) and Market Share (%) of Major Companies
Table 5: Hospital Supplies Market, France, Revenue ($M) and Market Share (%) of Major Companies
Table 6: Orthopedic Devices Market, France, Revenue ($M) and Market Share (%) of Major Companies
Table 7: Ophthalmic Devices Market, France, Revenue ($M) and Market Share (%) of Major Companies
Table 8: Actual Clinical Benefit (ACB), France, 2018
Table 9: Clinical Added Value (CAV), France, 2018
Table 10: Rreimbursement Rates for Medical Procedures and Services Covered by Health Insurance Schemes, France, 2019
Table 11: Pricing Based on ASMR Level, France, 2018
Table 12: Patent Fees, France, 2018
Table 13: Trademark Fees, France, 2018
Table 14: Label of a Pharmaceutical Product, France, 2017
Table 15: Minimum particulars to appear on blisters or strips , France, 2017
Table 16: Minimum particulars to appear on small immediate packaging , France, 2017
List of Figures
Figure 1: Pharmaceutical Market, France, Revenue ($B), 2010-2017
Figure 2: Medical Device Market, France, Revenue ($B), 2015-2020
Figure 3: Number of Deals (2018-2019)
Figure 4: 2018-19 Deal Overview By Region
Figure 5: Country Profile, France, 2018
Figure 6: Pharmaceutical Market, France, Revenue ($B), 2010-2017
Figure 7: Pharmaceutical Market, France, Revenue Forecast ($B), 2018-2022
Figure 8: Pharmaceutical Market, France, Pharmaceutical Exports
Figure 9: Pharmaceutical Market, France, Top Export Partners
Figure 10: Pharmaceutical Market, France, Pharmaceutical Imports
Figure 11: Pharmaceutical Market, France, Top Import Partners
Figure 12: Marketing Authorizations for Generic Medicines, France, 2012-2017
Figure 13: Availability of Biologics in Healthcare Settings, France, 2017
Figure 14: Competitiveness Clusters , France, 2017
Figure 15: Government Funded Biosimilars, France, 2017
Figure 16: Pharmaceutical OTC Market, France, Revenue ($B), 2010-2017
Figure 17: Major OTC Drug Classes (Share%), France, 2017
Figure 18: Pharmaceutical Market, France, Supply Channels
Figure 19: Pharmaceutical Market, France, Sales of Patented Drug Products by Major Therapeutic Class at Ex factory Prices (%), 2017
Figure 20: Pharmaceutical Market, Major Players, France
Figure 21: Medical Device Market, France, Revenue ($B), 2015-2020
Figure 22: Medical Device Market, France, Revenue Forecast ($B), 2021-2025
Figure 23: Medical Device Market, France, Revenue by Segment ($B), 2018
Figure 24: IVD Market, France, Revenue ($B), 2015-2022
Figure 25: IVD Market, France, Market Share of Major Players (%)
Figure 26: Cardiovascular Devices Market, France, Revenue ($B), 2015-2022
Figure 27: Cardiovascular Devices Market, France, Market Share of Major Players (%)
Figure 28: Hospital Supplies, France, Revenue ($B), 2015-2022
Figure 29: Hospital Supplies, France, Market Share of Major Players (%)
Figure 30: Orthopedic Market, France, Revenue ($B), 2015-2022
Figure 31: Orthopedic Devices Market, France, Market Share of Major Players (%)
Figure 32: Ophthalmic Devices Market, France, Revenue ($B), 2015-2022
Figure 33: Ophthalmic Devices Market, France, Market Share of Major Players (%)
Figure 34: Diagnostic Market, France, Revenue ($B), 2015-2018
Figure 35:Diagnostic Market, France, Revenue Forecast ($B), 2019-2022
Figure 36: Medical Device Market - Major Players
Figure 37: Deal Value and Deal Count, Pharmaceutical Market, France, 2018-2019
Figure 38: Deal Value and Deal Count Quarterly, Pharmaceutical Market, France, 2018-2019
Figure 39: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, France, 2018-2019
Figure 40: Top Five Therapy Areas by Deal Value, Pharmaceutical Market, France, 2018-2019
Figure 41: Top Five Therapy Areas by Deal Number, Pharmaceutical Market, France, 2018-2019
Figure 42: M&A Deals by Therapy Area, Pharmaceutical Market, France, 2018-2019(by value and by number)
Figure 43: Venture Financing Deals by Therapy Area, Pharmaceutical Market France, 2018-2019(by value and by number)
Figure 44: Private Equity Deals by Therapy Area, Pharmaceutical Market France, 2018-2019(by value and by number)
Figure 45: Medical Device Market Deals, France, 2018-2019(by deal value, $M)
Figure 46: Medical Device Market Deals, France, 2018 -2019(by deal count)
Figure 47: Medical Device Market Deals Share (by deal count), France, 2018 - 2019
Figure 48: Medical Device Market Deals Share (by deal value), France, 2018 - 2019
Figure 49: Top Five Therapy Areas by Deal Value, Medical Device, France, 2018-2019
Figure 50: Top Five Therapy Areas by Deal Number, Medical Device, France, 2018-2019
Figure 51: M&A Deals by Therapy Area, Medical Device, France, 2018-2019 (by number)
Figure 52: Venture Financing Deals by Therapy Area, Medical Device, France, 2018-2019(by value and by number)
Figure 53: Private Equity Deals by Therapy Area, Medical Device France, 2018-2019(By number)
Figure 54: Healthcare System, France, 2018
Figure 55: Workflow of Healthcare System, France, 2018
Figure 56: Medicine Assessment Process, France, 2018
Figure 57: Medical Device Assessment Process, France, 2018
Figure 58: Network of Public Insurance Providers, France, 2018
Figure 59: Revenue Structure of CNAM, France, 2017
Figure 60: Funding by Mutuals, France, 2018
Figure 61: Funding by Provident Institutions, France, 2018
Figure 62: Funding by Insurance Companies, France, 2018
Figure 63: OOP Expenditure (% of total expenditure on health), France, 2010-2016
Figure 64: Annual Rate of Change (%), Health Price Index, France, 2010-2019
Figure 65: Pricing Process, France, 2019
Figure 66: The Evolution of the Price of Drugs, France, 2018
Figure 67: ANSM, Organizational Structure, France, 2019
Figure 68: National Procedure, France, 2017
Figure 69: Centralized Procedure, 2018
Figure 70: Decentralized Procedure, 2018
Figure 71: Mutual Recognition Procedure, 2018
Figure 72: Conformity Assessment of Class I Medical Devices, EU, 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report